PRINCETON, N.J., Feb. 4, 2011 /PRNewswire/ — Novo Nordisk
announced today the availability of Coags Uncomplicated – the
first mobile application (app) to assist in the diagnosis of
bleeding disorders – created in partnership with Craig
Kessler, MD, Professor of Medicine and Pathology and Director of
the Coagulation Laboratory, Georgetown University Hospital,
Lombardi Comprehensive Cancer Center. Coags Uncomplicated features
a Lab Value Analyzer that enables physicians to input test results
and receive a list of potential diagnoses to consider including a
description of each bleeding disorder and typical lab values.
The app also provides step-by-step suggestions for
appropriate lab tests to narrow possible diagnoses.
With the potential to help clinicians quickly and more
accurately diagnose bleeding disorders, the app provides for the
first time, in one place, information about bleeding disorders and
their effects on coagulation laboratory tests.
“While physicians are increasingly using hand-held devices to
access medical information, no such tool has existed to help with
the diagnosis of bleeding disorders, especially when getting to the
correct diagnosis quickly may be critical,” said Eddie Williams,
Vice President, Biopharmaceuticals. “Novo Nordisk was pleased
to collaborate with Dr. Kessler on this innovative approach to
addressing an unmet need, further demonstrating our commitment to
the bleeding disorder community.”
The basis for the app came from U.S. market research results,
which identified a gap in many specialists’ recognition of abnormal
blood clotting activity in a bleeding patient; often resulting in a
focus on the location of the bleed rather than the cause.
These findings were presented at the 2010 American Society of
Hematology (ASH) Annual Meeting.
The Coags Uncomplicated app is available for free download at www.coagsuncomplicated.com.